Fibroblast growth factor signaling in embryonic and cancer stem cells.
about
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitorsFGFR1 is an adverse outcome indicator for luminal A breast cancers.Multicell simulations of development and disease using the CompuCell3D simulation environmentGonad RNA-specific qRT-PCR analyses identify genes with potential functions in schistosome reproduction such as SmFz1 and SmFGFRs.Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal CellsAngiogenesis-independent tumor growth mediated by stem-like cancer cells.Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors.Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway.High molecular weight FGF2: the biology of a nuclear growth factor.Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human mesenchymal stromal cells.FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathwayA molecular dynamics-based algorithm for evaluating the glycosaminoglycan mimicking potential of synthetic, homogenous, sulfated small molecules.The implications of cancer stem cells for cancer therapy.Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells.Axin2 expression identifies progenitor cells in the murine prostate.Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy.The relationship between early embryo development and tumourigenesis.Perspectives on cancer stem cells in osteosarcomaSignals controlling un-differentiated states in embryonic stem and cancer cells: role of the phosphatidylinositol 3' kinase pathway.Non-canonical activity of retinoic acid in epigenetic control of embryonic stem cellCell-based tissue engineering strategies used in the clinical repair of articular cartilageIntracellular trafficking of endogenous fibroblast growth factor-2.Niche-mediated control of human embryonic stem cell self-renewal and differentiation.Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.Fibroblast growth factor type 2 signaling is critical for DNA repair in human keratinocyte stem cells.Autophagy regulates cytoplasmic remodeling during cell reprogramming in a zebrafish model of muscle regeneration.Cancer stem cell surface markers on normal stem cells.Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinaseFibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling.Unconventional Protein Secretion in Animal Cells.Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair.
P2860
Q24298832-295E749A-C445-4193-9D25-10F1FB735C3BQ27853294-A99D5419-EAD3-4423-8CD5-C27A9B4CE8FFQ29906828-2CDDFAE1-C61E-40A3-974D-8AB173671874Q33730904-71E1B877-F0E5-4AC9-8C32-3BB215DCCC6BQ34305653-DA607C7F-33B5-4A72-8662-2EBEB4BC0D7BQ35103863-C47BFE71-68DF-4FAC-8E99-7D7C9E40A30BQ35394635-36E877EF-6BF5-463F-AEE1-EB1DED1F0BBEQ35590284-DC3DA235-F8F4-40BE-9BD0-A71F9E23C965Q35590328-3F8C81B4-93FC-4337-A53A-A83EADFDB0BEQ35855686-D4DD64A0-ED67-4CA1-AD75-BBD47B5A8F8AQ35883412-155739F8-C2CA-4F2E-B61F-806B2E33B632Q36275692-53C94BEA-EF1B-470C-8313-4A9A8B5E94EAQ36538487-D62F9ACF-1B58-45FF-A87C-8EA8234151B3Q36675601-CE651B87-FF30-43C8-8D24-E3B64A17C0F0Q36811483-55FB40BC-8BA6-494B-80E3-08B6535B88F5Q36994927-4D60D916-0827-48F8-81C1-79CC29BCF674Q37010405-C41F0B4D-3F73-4D39-AFCF-B36E7F779E73Q37294300-C8856B38-4AEA-4064-996B-3B54128F8B5FQ38015689-B2FF965F-CFB8-4615-986B-532C87BED6DFQ38194093-C82724F7-ACB2-472A-895D-C1B3C1F3774DQ38636512-D3D324BC-9BE0-4B7D-97E2-3F7AA317F8E0Q38833861-1A7E7380-7DA5-4F3D-A959-BFE8C90BF4CDQ40007223-CCEC9C7E-2234-4D6F-B05D-8868185F076AQ40065333-D5C55576-23A1-443F-891F-3A6AE0C2BC99Q41241610-D6EDCAE4-EB4F-4524-BB95-259B262A7F88Q41285133-5A751D6F-828D-4033-99DA-2DDFC95D58EAQ41479076-06BBB02D-9BCD-400A-8CC6-A40748CA2D68Q42332008-2CFDA354-97A8-43DE-A32B-CA38535A5F41Q42575382-E0085775-3BC6-42C6-B538-86C1740FBEE5Q42914079-A468E646-1AA0-4614-86E7-D264831882DBQ43296119-BD5C8453-751E-4FF6-8D33-A2F78A7D6DF0Q51154268-DD3F4C5E-D4F7-40BD-8F91-D999F7B91098Q55398286-1722BE6C-CBEB-4410-AAD9-49891E177A15
P2860
Fibroblast growth factor signaling in embryonic and cancer stem cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Fibroblast growth factor signaling in embryonic and cancer stem cells.
@ast
Fibroblast growth factor signaling in embryonic and cancer stem cells.
@en
type
label
Fibroblast growth factor signaling in embryonic and cancer stem cells.
@ast
Fibroblast growth factor signaling in embryonic and cancer stem cells.
@en
prefLabel
Fibroblast growth factor signaling in embryonic and cancer stem cells.
@ast
Fibroblast growth factor signaling in embryonic and cancer stem cells.
@en
P2860
P1433
P1476
Fibroblast growth factor signaling in embryonic and cancer stem cells
@en
P2093
Dana Dvorakova
P2860
P304
P356
10.1016/J.FEBSLET.2006.01.095
P407
P577
2006-02-28T00:00:00Z